Resistência medicamentosa em hanseníase: vigilância de pacientes atendidos na Fundação Alfredo da Matta, Manaus -Am
Carregando...
Arquivos
Data
Título da Revista
ISSN da Revista
Título de Volume
Editor
Universidade do Estado do Amazonas
Resumo
Leprosy  is  a  chronicinfectiousdisease  with  slow  evolution  that  results  in dermatoneurological  disorders. It  is  caused  by Mycobacterium  leprae,  an obligateintracellular parasite. In 2018, 208,619 new cases of the disease were diagnosed in the world, with Brazil being the second country with the highest number of cases, just behind India. In 2009, the World Health Organization proposed the creation of a drug resistance  surveillance  network  in  leprosy,  since  the  emergence  and  spread  of resistant  strains  pose  a serious  threat  to  disease  control  strategies.  In  view  of  this, the  objective  of  this  work  was  to evaluate  the  occurrence  ofM.  lepraeresistant strains through the investigation of polymorphisms in thefolp1, rpoBand gyrAgenes, which confer resistance tothe drugs dapsone, rifampicin and ofloxacin respectively. This was a descriptive, retrospective study in leprosy patients,attended at Fundação Alfredo  da  Matta,  Manaus -AM,  during  the  period  from  2017  to  2019.The patients selected for the study (N=65)were divided into two groups: new casesand relapse, for  the  evaluation  of  primary  and  secondary resistance.  There  was  a  predominance of  males,  with  an  average  age  of  50  years,  mixed  race  and  low  level  of  education. The  Virchowian  clinical  form  was  the  most  prevalentand  all  new  cases  were multibacillary  patients.  Of  the  studied  genes,  the folp1 gene  obtained  the  highest amplification index (98,46%), followed by the rpoBgene (88,15%) and the gyrAgene (81,54%). One  sample  showeda  mutation  in  the  studied  genes,  it  was  a  point mutation in codon 55 of the folp1 gene, conferring secondary resistance to dapsone in a sample of a relapsed patient.This is not an isolated report of a resistancecasein  patients from the  AmazonasState,  whether  it  is  a  new  case  or  a relapse. Therefore,  the  continuity  of  surveillance  on leprosy drug  resistance is  extremely important. Due to the small number of samplesanalyzed in the present research, it is believed  that  does  not  represent  the  real  scenario  of resistant strains circulation  in the region
